Moreover, CIS samples exhibited a higher mutational rate in genes of the TP53/cell cycle pathway compared to pTa HG/papillary pT1 HG lesions (72% vs. 47%), mainly due to differences in the alteration frequencies of TP53 and CCND1 [11]. Here, TP53 is linked to in situ carcinoma.